Building new companies that leverage technological innovation to transform the health care system requires much more than ample capital. Echo Health Ventures was built upon the belief that corporate investors, working together, are best positioned to sustainably bring this multi-faceted value to the health care innovation economy for the next generation of entrepreneurs.
Parent companies' boards have appointed Rob Coppedge as CEO, will lead the combined strategic investment company.
Mosaic Health Solutions and Cambia Health Solutions collaborate to create a better health care experience for consumers.
Echo Health Ventures’ portfolio companies are committed to personalizing health care, reducing costs and creating a better experience for consumers. We invest across every stage and work with our portfolio companies to challenge and transform the health care system.
Chief Executive Officer Rob Coppedge discusses a bold new approach to corporate investing focused on building a health care system centered system centered on people and their families.
Consumer satisfaction with the health care experience is low -- Echo Health Ventures is investing in companies that challenge the traditional model.
The acquisition of AxisPoint Health will build on the company’s strengths of improving health outcomes, simplifying complex care, and directing members to the right care at the right time.
Telcare Pioneers Development of the First Cellular-Enabled Glucometer, Secures Patent Allowance for Critical Technology That Supports Improved Diabetes Management
Telcare's first-of-its-kind diabetes monitoring technology delivers accurate, sensitive medical data to patients and providers in near-real time.
Touchcare’s mobile app connects patients to their providers over secure video, improving access and enhancing convenience of care.
The Community Eye Care provider network is the largest eye network in North Carolina, ensuring unmatched access to eye care.
Telcare receives a Series C round of funding to enhance its groundbreaking diabetes monitoring technologies.
Investors are pleased with the market’s response to iChip, a mobile platform that delivers personalized health information and analytics to consumers and their doctors.